Alopecia Treatment Market, By Drug Class, By Disease Type, By Route of Administration, By Distribution Channel, By geography

Description

Global alopecia treatment market is estimated to be valued at US$ 9.65 Bn in 2023, and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 9.65 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.60%	2030 Value Projection:	US$ 14.16 Bn

Figure 1. Global Alopecia Treatment Market Share (%), By Drug Class, 2023

Alopecia is a medical term that is used to describe the partial or complete loss of hair from areas of the body where hair is normally found. This condition can affect the scalp, eyebrows, eyelashes, beard, or any other part of the body where hair grows. Alopecia can be temporary or permanent, and can occur due to a variety of factors including genetic predisposition, hormonal changes, autoimmune disorders, medical treatments, and certain environmental or psychological factors. There are several types of alopecia, each with distinct characteristics and underlying causes. These include alopecia areata (characterized by patchy hair loss), androgenetic alopecia (commonly known as male-pattern or female-pattern baldness), telogen effluvium (sudden and widespread hair shedding), traction alopecia (caused by repeated pulling or tension on the hair), and others.

Market Dynamics

The key players in operating in the market are focusing on organic growth strategies such as fund raising for alopecia is expected to propel the global alopecia treatment market growth over the forecast period. For instance, in July 2023, Mallia Therapeutics GmbH, a biopharmaceutical company that is developing soluble CD83 (sCD83) for the treatment of hair loss, announced that it had secured its seed financing. The company plans to develop the sCD83 candidate based on preclinical and ex vivo human data, presented at the 20th meeting of the European Hair Research Society (EHRS) held in Sheffield, UK, in June 2023. sCD83 can be applied topically to reach the hair follicle, which is a big advantage as compared to systemic treatment options. Mallia Therapeutics GmbH develops the dual mode of action of sCD83 for the treatment of hormone-induced male or female pattern baldness (= androgenetic alopecia) and autoimmune mediated male or female patchy hair loss (= alopecia areata), the two most prevalent forms of hair loss. Moreover, increasing research and development activities for alopecia treatment is expected to drive global alopecia treatment market growth over the forecast period. For Instance, In November 2022, Equillium, Inc., a clinical-stage biotechnology company, announced that it had initiated a Phase 2 open-label study of EQ101 to assess efficacy and safety in adult subjects with moderate to severe alopecia areata. The study is expected to enroll approximately 30 subjects at multiple clinical sites in Australia.

Key features of the study:

This report provides an in-depth analysis of the global alopecia treatment market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global alopecia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Stemson Therapeutics, OliX Pharmaceuticals, Inc, Pfizer Inc, Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy's Laboratories Ltd., Himalaya Wellness Company, Stemson Therapeutics, Cosmo Pharmaceuticals N.V., Equillium, Inc., Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global alopecia treatment market

Detailed Segmentation:

Global Alopecia Treatment Market, By Drug Class:
- Corticosteroids
- 5 AR Inhibitors
- Vasodilators
- Others
Global Alopecia Treatment Market, By Disease Type:
- Alopecia Areata
- Androgenic Alopecia
- Traction Alopecia
- Others
Global Alopecia Treatment Market, By Route of Administration:
- Topical
- Oral
- Injectable
Global Alopecia Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Alopecia treatment Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Stemson Therapeutics .
- OliX Pharmaceuticals, Inc
- Pfizer Inc
- Aclaris Therapeutics, Inc.
- Fagron
- Follicum AB
- Cipla Inc.,
- Arcutis Biotherapeutics
- Dr. Reddy's Laboratories Ltd.,
- Himalaya Wellness Company
- Stemson Therapeutics
- Cosmo Pharmaceuticals N.V.
- Equillium, Inc.
- Eli Lilly and Company
- Concert Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.

Product Code: CMI1847

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Disease Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Recent Trends
Mergers, Acquisitions, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
PORTER's Analysis

4. Global Alopecia Treatment Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Alopecia Treatment Market, By Drug Class, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
5 AR Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Vasodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

6. Global Alopecia Treatment Market, By Disease Type, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Alopecia Areata
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Androgenic Alopecia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Traction Alopecia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Alopecia Treatment Market, By Route of Administration, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

8. Global Alopecia Treatment Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

9. Global Alopecia Treatment Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
North America
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
U.S.
Canada
Europe
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018 - 2030, (US$ Bn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Company Profiles
- Stemson Therapeutics .
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- OliX Pharmaceuticals
- Pfizer Inc
- Aclaris Therapeutics
- Fagron,
- Follicum AB
- Cipla Inc.
- Arcutis Biotherapeutics
- Dr. Reddy's Laboratories Ltd
- Himalaya Wellness Company
- Cosmo Pharmaceuticals N.V.
- Equillium, Inc.
- Eli Lilly and Company
- Concert Pharmaceuticals Inc
- Teva Pharmaceutical Industries Ltd.
Analysts' Views

11. Section

References
Research Methodology
About Us and Sales Contact